MED1 and prostate neoplasm: We assessed the interaction between AR and phosphorylated MED1 in clinical prostate tumor specimens (57 cases) using proximity ligation assays (PLA), and revealed that it occurred in CRPC specimens, and not in benign prostate tissues or muscles (Figure 5C and Supplementary Figure S5E).